Reactivity with the peripheral myelin glycoprotein P0 in serum from patients with monoclonal IgM gammopathy and polyneuropathy
- PMID: 2456490
- DOI: 10.1212/wnl.38.8.1266
Reactivity with the peripheral myelin glycoprotein P0 in serum from patients with monoclonal IgM gammopathy and polyneuropathy
Abstract
The major glycoprotein P0 from human and bovine peripheral nerves carries the L2/HNK-1 and L3 carbohydrate epitopes and is recognized by serum from patients with IgM gammopathy and polyneuropathy. Only serum from patients with reactivity toward the myelin-associated glycoprotein (MAG) was reactive with P0, while serum that did not react with MAG also did not recognize P0. Furthermore, the neural adhesion molecules L1, N-CAM, and J1 were also recognized by the serum that reacted with MAG, while the L3 carbohydrate-carrying cell adhesion molecule AMOG was not recognized. These observations indicate a restricted specificity in carbohydrate reactivity of IgM paraproteins and implicate yet another and, for the first time, peripheral myelin-specific glycoprotein in the pathogenesis of demyelinating neuropathy.
Similar articles
-
Reactivity with neural cell adhesion molecules in sera from patients with demyelinating diseases.Neurosci Lett. 1986 Apr 11;65(2):199-203. doi: 10.1016/0304-3940(86)90304-6. Neurosci Lett. 1986. PMID: 2423924
-
[Polyneuropathies and gammapathies: a form with antiglycoprotein MAG antibodies].Rev Neurol (Paris). 1984;140(1):28-36. Rev Neurol (Paris). 1984. PMID: 6198705 French.
-
Molecular specificity of L2 monoclonal antibodies that bind to carbohydrate determinants of neural cell adhesion molecules and their resemblance to other monoclonal antibodies recognizing the myelin-associated glycoprotein.Brain Res. 1986 Oct 22;385(2):237-44. doi: 10.1016/0006-8993(86)91069-3. Brain Res. 1986. PMID: 2430667
-
Myelin-associated glycoprotein in development and disease.Dev Neurosci. 1983-1984;6(6):285-303. doi: 10.1159/000112356. Dev Neurosci. 1983. PMID: 6085570 Review.
-
Myelin-associated glycoprotein in demyelinating disorders.Crit Rev Neurobiol. 1989;5(1):1-28. Crit Rev Neurobiol. 1989. PMID: 2475262 Review.
Cited by
-
A randomised clinical trial comparing interferon-alpha and intravenous immunoglobulin in polyneuropathy associated with monoclonal IgM. The IgM-associated Polyneuropathy Study Group.J Neurol Neurosurg Psychiatry. 1997 Jul;63(1):28-34. doi: 10.1136/jnnp.63.1.28. J Neurol Neurosurg Psychiatry. 1997. PMID: 9221964 Free PMC article. Clinical Trial.
-
Antiglycolipid antibodies in peripheral neuropathy: fact or fiction?J Neurol Neurosurg Psychiatry. 1994 Nov;57(11):1303-7. doi: 10.1136/jnnp.57.11.1303. J Neurol Neurosurg Psychiatry. 1994. PMID: 7964802 Free PMC article. Review. No abstract available.
-
Identification of monoclonal antibody At5 as a new member of HNK-1 antibody family: the reactivity with myelin-associated glycoprotein and with two brain-specific proteoglycans, phosphacan and neurocan.Neurochem Res. 1997 Feb;22(2):133-40. doi: 10.1023/a:1027355221525. Neurochem Res. 1997. PMID: 9016838
-
Polyneuropathy associated with IgM monoclonal gammopathy. Immunological and pathological study in 31 patients.Acta Neuropathol. 1989;79(2):160-7. doi: 10.1007/BF00294374. Acta Neuropathol. 1989. PMID: 2480693
-
Disease associations with monoclonal gammopathy of undetermined significance: a population-based study of 17,398 patients.Mayo Clin Proc. 2009 Aug;84(8):685-93. doi: 10.4065/84.8.685. Mayo Clin Proc. 2009. PMID: 19648385 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous